Clinical trial
CAPA In-vitro Oocyte Maturation
NCT06984081 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAPA In-vitro Oocyte Maturation
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 10, 2025
- Completion date
- May 31, 2032
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.